It has been hypothesized that cancer cells deficient in p53 function, due to p53 mutations or other defects in the p53 signaling pathway, lack a G1 cell cycle checkpoint and therefore may depend more on the G2 checkpoint for cell survival [74,75,76]. The gene discussed is TP53; the disease is cancer.